NMI控股 NMIH 深 沪
等待开盘 10-21 09:30:00 美东时间
36.13
+0.360
+1.01%
华盛通- 最 高36.1698
- 今 开35.87
- 成交量 23.52万股
- 最 低 35.58
- 昨 收 35.77
- 总市值 28.03亿
- 52周最高 43.20
- 市盈率 静 8.15
- 换手率 0.30%
- 52周最低 31.90
- 委 比 33.12%
- 总股本 7757.41万
- 历史最高 43.20
- 量 比 0.65
- 振 幅 1.65%
- 历史最低 4.19
- 每 手 1
- 风险率 2.06%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅4347.41%！Ascendiant Capital上调PAVmed目标价至20美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持PAVmed"买入"评级，目标价从19美元升至20美元；Ascendiant Capital：维持Plus Therapeutics"买入"评级，目标价从20.5美元升至21美元
10-07 15:04
Barclays Maintains Equal-Weight on NMI Holdings, Raises Price Target to $43
Barclays analyst Terry Ma maintains NMI Holdings (NASDAQ:NMIH) with a Equal-Weight and raises the price target from $42 to $43.
10-06 21:20
NovaBay Pharmaceuticals Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar
NovaBay Pharmaceuticals has entered into a $6 million securities purchase agreement with private investor David E. Lazar, receiving the first closing of $3.85 million. Lazar has been appointed CEO, while former CEO Justin Hall becomes Vice President of Business Development. The transaction prevents NovaBay’s liquidation and allows its shares to continue trading. Proceeds will fund strategic investments or acquisitions, and a special cash dividend...
08-19 21:25
Earnings Scheduled For July 29, 2025
Companies Reporting Before The Bell • Barclays (NYSE:BCS) is projected to repor...
07-29 16:32
A Look at NMI Holdings's Upcoming Earnings Report
NMI Holdings (NASDAQ:NMIH) is preparing to release its quarterly earnings on Tu...
07-29 02:02
NMI Holdings, Inc. to Announce Second Quarter 2025 Financial Results on July 29, 2025
<p>NMI Holdings, Inc. (NASDAQ: NMIH) announced it will report its second quarter 2025 results after market close on July 29, 2025. A conference call and live webcast will be held at 2:00 p.m. PT / 5:00 p.m. ET, accessible via the company's website or by phone. The webcast and earnings materials will be available for replay on the site.</p>
07-14 14:04
美股大行评级 | 潜在涨幅62.34%！NioCorp Developments获Maxim Group升目标价至5美元，维持"买入"评级
今日重点评级关注：Maxim Group：维持NioCorp Developments"买入"评级，目标价从4美元升至5美元；花旗：维持BridgeBio Pharma"买入"评级，目标价从58美元升至67美元
07-14 08:34
Sezzle, Futu, SoFi, MGIC among week's biggest financial movers
The financials sector (XLF) logged a 1.9% decrease this trading week, as tariff jitters weighed on the broader stock market (SPX), which slipped 0.3%. Sezzle (SEZL), which during the week filed an ant...
07-12 22:10
美股大行评级 | 潜在涨幅687%！ 花旗上调新氧科技目标价升至5.5美元，评级"买入"
今日重点评级关注：B. Riley证券：维持内克塔治疗"买入"评级，目标价从60美元升至85美元；Oppenheimer：维持Praxis Precision Medicine"跑赢大市"评级，目标价从97美元升至115美元
07-09 09:26
美股大行评级 | 潜在涨幅199.47%！杰富瑞上调Cogent Biosciences目标价至28美元，维持"买入"评级
今日重点评级关注：杰富瑞：维持Cogent Biosciences"买入"评级，目标价从23美元升至28美元；Leerink Partners：维持Cogent Biosciences"跑赢大市"评级，目标价从16美元升至18美元
07-08 09:34
